Effect of Donated Plasma on Laboratory Parameters and Motivating Factors of Donated Plasma

Author(s)

Czifra I1, Vajda R2, Kajos L3, Kovács B4, Boncz I4, Kívés Z5
1University of Pécs, Institute for Health Insurance, Pécs, Hungary, Hungary, 2University of Pécs, Pécs, Hungary, 3University of Pécs, Pécs, BA, Hungary, 4University of Pécs, BUDAPEST, PE, Hungary, 5University of Pécs, PÉCS, BA, Hungary

Presentation Documents

OBJECTIVES: Medical therapeutic blood products, such as plasma-derived drugs, play a crucial role in health care. This research aims to reveal the motive for donating plasma among donors and to examine the changes in laboratory results during the donation.

METHODS: The retrospective research was conducted in a plasma centre in Hungary between 01.01.2019. and 30.12.2022(n=100). Scope of collected data: gender, haemoglobin (HGB), thrombocyte (PLT) hematocrit (HTC), red blood cell (RBC), white blood cell (WBC), total protein level, after the first (1st), fifth (5th) and fifteenth (15th) plasma donation. The cross-sectional survey was conducted among donors aged 18-65 (n=200). The questionnaire covered sociodemographic data, information sources, number of weekly plasma donations and motivation. Descriptive statistical analysis and repeated ANOVA (p<0.05) were performed using SPSS 28.0 software.

RESULTS: The RBC count (1st: 4.94 T/L; 5th: 4.77 T/L; 15th: 4.68 T/L), the WBC count (1st: 6.79 G/L; 5th: 6.61 G/L; 15th: 6.54 G/L and PLT count (1st: 199.57 G/L; 5th: 192.56 G/L; 15th: 186.15 G/L) decreased significantly (p<0.001), but remained within the normal range. The level of HMG of women (1: 130 G/L; 15: 127 G/L) (p<0.001) and men (1: 145.6 G/L; 15: 137.1 G/L) significantly decreased (p<0.001). Total plasma protein (1st: 7.7 G/L; 5th: 7.1 G/L; 15th: 6.7 G/L) also decreased (p<0.001) but remained in the normal range. The primary sources of information comprise a friend (41.5%) and the Internet (36%). The main motive is helping others (70%) and benefits (54%). The main motive for later plasma donation is more benefits (67.5%). 45.5% of respondents plan to donate plasma 3-4 times a month, 42% at most.

CONCLUSIONS: All donor parameters tested decreased during donation but remained within the normal range. The benefits are still a source of motivation.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

CO51

Topic

Clinical Outcomes, Epidemiology & Public Health, Medical Technologies, Study Approaches

Topic Subcategory

Clinical Outcomes Assessment, Clinical Trials, Diagnostics & Imaging, Public Health

Disease

Biologics & Biosimilars, Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×